Japan · Delayed Price · Currency is JPY Xebio Holdings Statistics
Total Valuation
Xebio Holdings has a market cap or net worth of JPY 46.89 billion. The enterprise value is 36.79 billion.
| Market Cap | 46.89B |
| Enterprise Value | 36.79B |
Important Dates
The last earnings date was Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | Sep 29, 2026 |
Share Statistics
Xebio Holdings has 41.38 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 41.38M |
| Shares Outstanding | 41.38M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.58% |
| Owned by Insiders (%) | 8.38% |
| Owned by Institutions (%) | 14.43% |
| Float | 20.56M |
Valuation Ratios
The trailing PE ratio is 127.77.
| PE Ratio | 127.77 |
| Forward PE | n/a |
| PS Ratio | 0.18 |
| PB Ratio | 0.39 |
| P/TBV Ratio | 0.42 |
| P/FCF Ratio | 20.17 |
| P/OCF Ratio | 4.84 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.41, with an EV/FCF ratio of 15.83.
| EV / Earnings | 100.25 |
| EV / Sales | 0.14 |
| EV / EBITDA | 3.41 |
| EV / EBIT | 10.33 |
| EV / FCF | 15.83 |
Financial Position
The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.10.
| Current Ratio | 1.80 |
| Quick Ratio | 0.49 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 1.13 |
| Debt / FCF | 5.23 |
| Interest Coverage | 27.18 |
Financial Efficiency
Return on equity (ROE) is 0.10% and return on invested capital (ROIC) is 0.35%.
| Return on Equity (ROE) | 0.10% |
| Return on Assets (ROA) | 1.05% |
| Return on Invested Capital (ROIC) | 0.35% |
| Return on Capital Employed (ROCE) | 2.65% |
| Weighted Average Cost of Capital (WACC) | 4.56% |
| Revenue Per Employee | 104.77M |
| Profits Per Employee | 150,041 |
| Employee Count | 2,446 |
| Asset Turnover | 1.21 |
| Inventory Turnover | 1.80 |
Taxes
In the past 12 months, Xebio Holdings has paid 963.00 million in taxes.
| Income Tax | 963.00M |
| Effective Tax Rate | 89.25% |
Stock Price Statistics
The stock price has increased by +0.53% in the last 52 weeks. The beta is 0.27, so Xebio Holdings's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | +0.53% |
| 50-Day Moving Average | 1,122.94 |
| 200-Day Moving Average | 1,067.73 |
| Relative Strength Index (RSI) | 47.62 |
| Average Volume (20 Days) | 149,795 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Xebio Holdings had revenue of JPY 256.27 billion and earned 367.00 million in profits. Earnings per share was 8.87.
| Revenue | 256.27B |
| Gross Profit | 96.40B |
| Operating Income | 3.56B |
| Pretax Income | 1.08B |
| Net Income | 367.00M |
| EBITDA | 10.79B |
| EBIT | 3.56B |
| Earnings Per Share (EPS) | 8.87 |
Balance Sheet
The company has 22.40 billion in cash and 12.15 billion in debt, with a net cash position of 10.25 billion or 247.77 per share.
| Cash & Cash Equivalents | 22.40B |
| Total Debt | 12.15B |
| Net Cash | 10.25B |
| Net Cash Per Share | 247.77 |
| Equity (Book Value) | 119.88B |
| Book Value Per Share | 2,893.12 |
| Working Capital | 62.83B |
Cash Flow
In the last 12 months, operating cash flow was 9.68 billion and capital expenditures -7.36 billion, giving a free cash flow of 2.32 billion.
| Operating Cash Flow | 9.68B |
| Capital Expenditures | -7.36B |
| Depreciation & Amortization | 7.23B |
| Net Borrowing | -564.00M |
| Free Cash Flow | 2.32B |
| FCF Per Share | 56.16 |
Margins
Gross margin is 37.62%, with operating and profit margins of 1.39% and 0.14%.
| Gross Margin | 37.62% |
| Operating Margin | 1.39% |
| Pretax Margin | 0.42% |
| Profit Margin | 0.14% |
| EBITDA Margin | 4.21% |
| EBIT Margin | 1.39% |
| FCF Margin | 0.92% |
Dividends & Yields
This stock pays an annual dividend of 35.00, which amounts to a dividend yield of 3.07%.
| Dividend Per Share | 35.00 |
| Dividend Yield | 3.07% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | 3.06% |
| Earnings Yield | 0.78% |
| FCF Yield | 4.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 28, 2006. It was a forward split with a ratio of 1.5.
| Last Split Date | Mar 28, 2006 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
Xebio Holdings has an Altman Z-Score of 2.54 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.54 |
| Piotroski F-Score | 6 |